Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenrong Zhou
Observed names:
Wen-Rong Zhou,
ZHOU Wenrong
Institution:
WuXi AppTec (China)
Observed institutions:
Shanghai Jiao Tong University,
WuXi AppTec (China)
OpenAlex ID:
A5109471708
MiR-140 is co-expressed withWwp2-Ctranscript and activated by Sox9 to targetSp1in maintaining the chondrocyte proliferation
2011
·
Jun Yang
, Shengying Qin
, et al.
·
FEBS Letters
·
156
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
2018
·
Jiye Liu
, Tianyu Song
, et al.
·
Leukemia
·
88
Foxp1/2/4 regulate endochondral ossification as a suppresser complex
2014
·
Haixia Zhao
, Wenrong Zhou
, et al.
·
Developmental Biology
·
75
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment
2021
·
Jiye Liu
, Teru Hideshima
, et al.
·
Science Advances
·
29
Ndrg2 regulates vertebral specification in differentiating somites
2012
·
Huang Zhu
, Jianzhi Zhao
, et al.
·
Developmental Biology
·
26
PDF
Tumor evolution selectively inactivates the core microRNA machinery for immune evasion
2021
·
Tian-Yu Song
, Min Long
, et al.
·
Nature Communications
·
20
PDF
Misexpression of Pknox2 in Mouse Limb Bud Mesenchyme Perturbs Zeugopod Development and Deltoid Crest Formation
2013
·
Wenrong Zhou
, Huang Zhu
, et al.
·
PLoS ONE
·
16
PDF
Genome-Wide CRISPR-Cas9 Screening Reveals a Role for TRAF2 in Resistance to IMiDs in Multiple Myeloma
2018
·
Jiye Liu
, Wenrong Zhou
, et al.
·
Blood
·
2
Abstract 1905: In vivo CRISPR screen identifies tumor suppressors as drivers of tumor cell-intrinsic immune evasion
2021
·
Chengyin Min
, Ferdinandos Skoulidis
, et al.
·
Cancer Research
·
1
Abstract 4631: SCFFbxo7 ubiquitin ligase targets cereblon to limit the anti-myeloma activity of IMiDs
2016
·
Jiye Liu
, Wenrong Zhou
, et al.
·
Cancer Research
·
1
Abstract B078: APMAP functions as a tumor-intrinsic target sensitizing cancer cells to macrophage-mediated phagocytosis
2025
·
Rachel Davidson
, Ye Wang
, et al.
·
Cancer Immunology Research
Abstract 2634: CRISPR in vivo screen utilizing removable Cas9 system to identify epigenetic immune response modulators in antigen-sensitive mouse syngeneic models
2024
·
Yuan He
, Yafei Liu
, et al.
·
Cancer Research
1425 In vivo CRISPR screens identify HDAC1 as an immune sensitizer reversing immune resistance driven by STK11 loss
2022
·
Chengyin Min
, Wenrong Zhou
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Abstract 5563: Development of an integrated in vitro and in vivo OVA-specific system for cancer vaccine discovery
2022
·
Jian Xiang
, Jun Huang
, et al.
·
Cancer Research
Abstract 1600: Cancer driver screens identifyregulators of immune checkpoint blockade therapy response
2021
·
Wenrong Zhou
, Zhengang Peng
, et al.
·
Cancer Research
Abstract 642: TRAF2 mediates sensitivity to immunomodulatory drugs via NF-κB and ERK signaling in myeloma cells
2020
·
Jiye Liu
, Teru Hideshima
, et al.
·
Cancer Research
Abstract 2154: Immune pressure selects ANKRD52 mutations for cancer cells to escape T cell-mediated killing
2020
·
Tianyu Y. Song
, Haixin Zhao
, et al.
·
Cancer Research
Abstract 2088: Comprehensive CRISPR screening unravel the different mechanisms of IMiDs resistance
2019
·
Wenrong Zhou
, Tianyu Song
, et al.
·
Experimental and Molecular Therapeutics
Abstract 3974: In vivo CRISPR-Cas9 library screen for liver cancer therapeutic targets essential for T cell killing
2019
·
Haixin Zhao
, Chenlu Geng
, et al.
·
Cancer Research
Abstract 2088: Comprehensive CRISPR screening unravel the different mechanisms of IMiDs resistance
2019
·
Wenrong Zhou
, Tianyu Song
, et al.
·
Cancer Research
Abstract 3974: In vivo CRISPR-Cas9 library screen for liver cancer therapeutic targets essential for T cell killing
2019
·
Haixin Zhao
, Chenlu Geng
, et al.
·
Clinical Research (Excluding Clinical Trials)
Abstract 785: Application of CRISPR/Cas9 gene editing to primary T cells
2018
·
Xi Li
, Wanbing Tang
, et al.
·
Cancer Research
Novel Mechanisms Underlying IMiDs Resistance in Multiple Myeloma: Therapeutic Implications
2017
·
Jiye Liu
, Wenrong Zhou
, et al.
·
Blood
Abstract A32: Screening for synthetic lethal interactions using customized epigenetic CRISPR-Cas9 libraries
2017
·
Wenrong Zhou
, Min Long
, et al.
·
Molecular Cancer Therapeutics
The value of combination of transabdominal ultrasound and transcavitary ultrasound in preoperative staging of bladder cancer
2015
·
ZHOU Wenrong
, WA Zengcheng
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Show more works
View as search
Works count:
25
Citation count:
414
H-index:
7
I10-index:
7
Year
Topic
Type